Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

被引:29598
作者
Bray, Freddie [1 ]
Ferlay, Jacques [1 ]
Soerjomataram, Isabelle [1 ]
Siegel, Rebecca L. [2 ]
Torre, Lindsey A. [2 ]
Jemal, Ahmedin [2 ]
机构
[1] Int Agcy Res Canc, Sect Canc Surveillance, 150 Cours Albert Thomas, F-69372 Lyon 08, France
[2] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA
关键词
cancer; epidemiology; incidence; survival; PROSTATE-CANCER; BREAST-CANCER; CERVICAL-CANCER; INTERPRETING TRENDS; ESOPHAGEAL CANCER; LATIN-AMERICA; PATTERNS; RISK; DEATHS; POPULATION;
D O I
10.3322/caac.21492
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. (c) 2018 American Cancer Society
引用
收藏
页码:394 / 424
页数:31
相关论文
共 82 条
[1]
Lung cancer incidence trends in Uruguay 1990-2014: An age-period-cohort analysis [J].
Alonso, Rafael ;
Pineros, Marion ;
Laversanne, Mathieu ;
Musetti, Carina ;
Garaua, Mariela ;
Barrios, Enrique ;
Bray, Freddie .
CANCER EPIDEMIOLOGY, 2018, 55 :17-22
[2]
[Anonymous], PROSTATE CANC
[3]
[Anonymous], 2005, IARC handbooks of cancer prevention, V10
[4]
[Anonymous], 2014, WORLD CANC REPORT 20
[5]
[Anonymous], 2016, HUMAN DEV REPORT 201
[6]
[Anonymous], J PATHOL
[7]
[Anonymous], 2018, J CANC EPIDEMIOL PRE, DOI DOI 10.1093/OSO/9780190238667.003.0061
[8]
[Anonymous], 1994, IARC MONOGRAPHS EVAL, V61, P177
[9]
[Anonymous], 2018, SCHOTTENFELD FRAUMEN
[10]
[Anonymous], 2007, Human papillomaviruses, V90, P1